Lifecore Biomedical Inc (LFCR)
6.28
-0.29
(-4.41%)
USD |
NASDAQ |
May 10, 16:00
6.296
+0.02
(+0.25%)
After-Hours: 20:00
Lifecore Biomedical Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | 32.97% |
| February 28, 2023 | 21.66% |
| November 30, 2022 | 18.32% |
| August 31, 2022 | 14.42% |
| May 31, 2022 | 35.18% |
| February 28, 2022 | 34.40% |
| November 30, 2021 | 33.86% |
| August 31, 2021 | 25.06% |
| May 31, 2021 | -11.83% |
| February 28, 2021 | 32.31% |
| November 30, 2020 | 15.76% |
| August 31, 2020 | 12.05% |
| May 31, 2020 | 4.20% |
| February 29, 2020 | 13.11% |
| November 30, 2019 | 10.88% |
| August 31, 2019 | 11.06% |
| May 31, 2019 | 17.16% |
| February 28, 2019 | 13.87% |
| November 30, 2018 | 13.56% |
| August 31, 2018 | 13.10% |
| May 31, 2018 | 17.59% |
| February 28, 2018 | 13.67% |
| November 30, 2017 | 12.18% |
| August 31, 2017 | 16.24% |
| May 31, 2017 | 24.15% |
| Date | Value |
|---|---|
| February 28, 2017 | 17.16% |
| November 30, 2016 | 13.95% |
| August 31, 2016 | 15.97% |
| May 31, 2016 | 26.16% |
| February 29, 2016 | 9.95% |
| November 30, 2015 | 12.29% |
| August 31, 2015 | 13.28% |
| May 31, 2015 | 13.89% |
| February 28, 2015 | 12.19% |
| November 30, 2014 | 11.81% |
| August 31, 2014 | 10.62% |
| May 31, 2014 | 13.35% |
| February 28, 2014 | 15.95% |
| November 30, 2013 | 11.44% |
| August 31, 2013 | 11.45% |
| May 31, 2013 | 12.16% |
| February 28, 2013 | 14.85% |
| November 30, 2012 | 16.10% |
| August 31, 2012 | 13.48% |
| May 31, 2012 | 17.80% |
| February 29, 2012 | 16.45% |
| November 30, 2011 | 15.95% |
| August 31, 2011 | 15.35% |
| May 31, 2011 | 15.48% |
| February 28, 2011 | 16.97% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-11.83%
Minimum
May 2021
35.18%
Maximum
May 2022
18.86%
Average
17.16%
Median
May 2019
Gross Profit Margin (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 63.59% |
| SELLAS Life Sciences Group Inc | -- |
| ADMA Biologics Inc | 42.06% |
| Relmada Therapeutics Inc | -- |
| Jaguar Health Inc | 70.13% |